Self-sterilizing medical devices market to reach $1.88 billion by 2030

The self sterilizing medical devices market is projected to grow from $0.98 billion in 2025 to $1.11 billion in 2026, as hospitals seek stronger infection prevention tools. The Business Research Company expects the market to nearly double to $1.88 billion by 2030, led by rising hospital-acquired infections, more surgeries and higher healthcare spending.

Why it matters: - Self sterilizing medical devices are designed to reduce microbial contamination without external sterilization, which can strengthen infection control in clinical settings. - The market is growing as hospitals look for ways to lower hospital-acquired infections, surgical site infections and cross-contamination risks. - Faster adoption could affect reusable instruments, operating rooms and other high-risk care environments.

What happened: - The Business Research Company published a 2026 market report on the self sterilizing medical devices sector. - The report estimates the market will rise from $0.98 billion in 2025 to $1.11 billion in 2026, a 13.7% CAGR. - The report forecasts the market will reach $1.88 billion by 2030, growing at a 14.0% CAGR. - North America held the largest regional share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also offers a free sample report and the full report online: Download a free sample and View the full report.

The details: - The report says growth is being driven by rising hospital-acquired infections, higher surgical hygiene standards, more reusable medical instruments, expanding hospital infrastructure in emerging economies and early use of antimicrobial coatings. - Future expansion is expected to be supported by self-disinfecting materials, autonomous infection prevention systems, minimally invasive surgery, healthcare infrastructure gains in developing regions and efforts to reduce cross-contamination. - Key trends include UV-C embedded sterilization in reusable instruments, antimicrobial coating innovation, stricter hospital-acquired infection prevention protocols, more regulatory validation requirements for autonomous sterilization and biocompatible self-disinfecting surfaces. - Self sterilizing medical devices use built-in technologies such as antimicrobial coatings, ultraviolet light and self-cleaning surfaces to reduce or eliminate microbial contamination. - The devices are intended to improve infection control, enhance patient safety and reduce dependence on traditional sterilization procedures. - Hospital-acquired infections are a major growth driver because they spread when infection control measures are weak, including poor hand hygiene, improper equipment sterilization and missed safety protocols. - In November 2024, the Australian Institute of Health and Welfare reported that during 2022-23, hospital-acquired complications affected 115,000 public hospitalizations and 34,200 private hospitalizations in Australia. - Healthcare-associated infections accounted for 37% of those complications, making them the most frequent issue. - The report also points to rising surgical volume as a growth catalyst because more procedures increase demand for contamination control. - Intuitive Surgical said its da Vinci systems were used in approximately 2,683,000 surgeries in early 2024, up from 2,286,000 in 2023 and 1,875,000 in 2022. - Higher healthcare spending is also supporting adoption of advanced infection control tools. - The Centers for Medicare and Medicaid Services said U.S. healthcare expenditures rose 7.5% in 2023 to $4.9 trillion, or about $14,570 per person.

Between the lines: - The forecast suggests infection prevention is moving from a routine hospital function toward a technology category with its own investment cycle. - Strong projected growth and regulatory validation requirements point to a market that could expand, but only if devices prove durable, safe and clinically effective. - The regional split suggests mature markets are still leading adoption, while developing markets may provide the next wave of growth as hospital infrastructure improves.

What's next: - The Business Research Company expects self sterilizing medical devices to benefit from more autonomous sterilization technologies and broader use in surgical and reusable instrument workflows. - Market watchers will likely focus on whether regulatory standards tighten further and whether hospitals accelerate procurement of self-disinfecting materials. - The next major test for the category is whether rising clinical demand translates into routine purchasing across more healthcare systems.

The bottom line: - Self sterilizing medical devices are moving from niche infection-control tools toward a fast-growing market tied to surgery volume, hospital safety pressure and healthcare spending.